{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:18:58Z","timestamp":1790173138367,"version":"4.1.0"},"reference-count":86,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3744,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1196\/annals.1361.113","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T20:08:07Z","timestamp":1125086887000},"page":"684-700","source":"Crossref","is-referenced-by-count":32,"title":["Anticytokine Therapy, Especially Anti-Interferon-\u03b3, as a Pathogenetic Treatment in TH-1 Autoimmune Diseases"],"prefix":"10.1111","volume":"1051","author":[{"given":"SIMON","family":"SKURKOVICH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BORIS","family":"SKURKOVICH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1196\/annals.1361.113-BIB1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/247551a0","article-title":"Immunosuppressive effect of an anti-interferon serum","volume":"247","author":"Skurkovich","year":"1974","journal-title":"Nature"},{"key":"10.1196\/annals.1361.113-BIB2","first-page":"356","article-title":"The probable role of interferon in allergy","volume":"35","author":"Skurkovich","year":"1975","journal-title":"Ann. Allergy"},{"key":"10.1196\/annals.1361.113-BIB3","unstructured":"3Skurkovich, S.V. & B. Skurkovich. 1989. Development of autoimmune diseases is connected with the initial disturbance of IFN synthesis in the cells. J. IFN Res. 9 (Suppl. 2): S305."},{"key":"10.1196\/annals.1361.113-BIB4","first-page":"344","article-title":"Lymphocytes' cytotoxicity towards cells of human lymphoblastoid lines in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"39","author":"Skurkovich","year":"1977","journal-title":"Ann. Allergy"},{"key":"10.1196\/annals.1361.113-BIB5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/acta.0.1220041","article-title":"Induction of experimental thyroiditis in mice by recombinant interferon gamma administration","volume":"122","author":"Kawakami","year":"1990","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1196\/annals.1361.113-BIB6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/clim.1999.4701","article-title":"Expression of interferon-gamma in the lens exacerbates anterior uveitis and induces retinal degenerative changes in transgenic Lewis rats","volume":"91","author":"Egwuagu","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1196\/annals.1361.113-BIB7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.410270306","article-title":"The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system","volume":"27","author":"Hartung","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1196\/annals.1361.113-BIB8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4049\/jimmunol.173.2.1051","article-title":"Requirements of NK cells and proinflammatory cytokines in T cell-dependent neonatal autoimmune ovarian disease triggered by immune complex","volume":"173","author":"Setiady","year":"2004","journal-title":"J. Immunol."},{"key":"10.1196\/annals.1361.113-BIB9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0896-8411(91)90021-4","article-title":"Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma","volume":"4","author":"Debray-Sachs","year":"1991","journal-title":"J. Autoimmun."},{"key":"10.1196\/annals.1361.113-BIB10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/endo.138.1.4846","article-title":"Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibody","volume":"13","author":"Nicoletti","year":"1997","journal-title":"Endocrinology"},{"key":"10.1196\/annals.1361.113-BIB11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/eji.1830230143","article-title":"The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells","volume":"23","author":"Tang","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1196\/annals.1361.113-BIB12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-5728(91)90019-4","article-title":"Interferon-gamma inhibition suppresses experimental allergic neuritis: modulation of major histocompatibility complex expression of Schwann cells in vitro","volume":"31","author":"Tsai","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1196\/annals.1361.113-BIB13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2249.1998.00527.x","article-title":"Essential pathogenic role for endogenous interferon-gamma (IFN-gamma) during disease onset phase of murine experimental autoimmune orchitis","volume":"111","author":"Itoh","year":"1998","journal-title":"I. In vivo studies. Clin. Exp. Immunol."},{"key":"10.1196\/annals.1361.113-BIB14","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.4049\/jimmunol.161.3.1542","article-title":"Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor","volume":"161","author":"Kageyama","year":"1998","journal-title":"J. Immunol."},{"key":"10.1196\/annals.1361.113-BIB15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199717020-00002","article-title":"Cytokine-induced autoimmune disorders","volume":"17","author":"Miossec","year":"1997","journal-title":"Drug Saf."},{"key":"10.1196\/annals.1361.113-BIB16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/ard.59.4.263","article-title":"Differential Th-1\/Th-2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies","volume":"59","author":"Canete","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1196\/annals.1361.113-BIB17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1043-4666(05)80008-0","article-title":"Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization","volume":"5","author":"Woodroofe","year":"1993","journal-title":"Cytokine"},{"key":"10.1196\/annals.1361.113-BIB18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-510X(88)90130-X","article-title":"Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions","volume":"84","author":"Traugott","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1196\/annals.1361.113-BIB19","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/00007890-199812150-00014","article-title":"Cytokine profiles of aqueous humor and graft in orthotopic mouse corneal transplantation","volume":"66","author":"Yamagami","year":"1998","journal-title":"Transplantation"},{"key":"10.1196\/annals.1361.113-BIB20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1084\/jem.185.3.531","article-title":"Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus","volume":"185","author":"Herrath","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1196\/annals.1361.113-BIB21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/archopht.1992.01080170084029","article-title":"Expression of cell adhesion molecules in posterior uveitis","volume":"110","author":"Whitcup","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1196\/annals.1361.113-BIB22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0923-1811(91)90019-T","article-title":"Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction","volume":"2","author":"Barker","year":"1991","journal-title":"J. Dermatol. Sci."},{"key":"10.1196\/annals.1361.113-BIB23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1196\/annals.1361.113-BIB24","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1046\/j.1523-1747.2003.12550_6.x","article-title":"Propionibacterium acnes-reactive T helper-1 cells in the skin of patients with acne vulgaris","volume":"121","author":"Mouser","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1196\/annals.1361.113-BIB25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.53.3.457","article-title":"TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study","volume":"53","author":"Lenercept Multiple Sclerosis Study Group and the University of British Columbia MS\/MRI Analysis Group","year":"1999","journal-title":"Neurology"},{"key":"10.1196\/annals.1361.113-BIB26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00054725-200401000-00004","article-title":"Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease","volume":"10","author":"Thomas","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1196\/annals.1361.113-BIB27","first-page":"23","article-title":"Successful first-time use of antibodies to interferon-gamma alone and combined with antibodies to tumor necrosis factor-alfa to treat rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, Behcet's syndrome)","volume":"14","author":"Skurkovich","year":"1998","journal-title":"Int. J. Immunotherapy"},{"key":"10.1196\/annals.1361.113-BIB28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/030097401316909530","article-title":"Randomized double-blind trial of anti-interferon-\u03b3 antibodies in rheumatoid arthritis","volume":"30","author":"Sigidin","year":"2001","journal-title":"Scan. J. Rheumatol."},{"key":"10.1196\/annals.1361.113-BIB29","unstructured":"29Loukina, G., Y. Sigidin, O. Pashkova, et al. 2004. Clinical response to anti-interferon (IFN)-gamma and anti-tumor necrosis factor (TNF)-alpha compared in Th1-mediated autoimmune disease-rheumatoid arthritis(RA)-and Th1\/Th2 disease (systemic lupus erythematosus (SLE)) [Abstract W51.46]. Twelfth International Congress of Immunology, Montreal."},{"key":"10.1196\/annals.1361.113-BIB30","first-page":"277","article-title":"Randomized study of antibodies to IFN-\u03b3 and TNF-\u03b1 in secondary progressive multiple sclerosis","volume":"7","author":"Skurkovich","year":"2001","journal-title":"Mult. Scler."},{"key":"10.1196\/annals.1361.113-BIB31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0002-9394(02)01433-2","article-title":"Treatment of corneal transplant rejection in humans with anti-interferon-gamma antibodies","volume":"133","author":"Skurkovich","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1196\/annals.1361.113-BIB32","unstructured":"32Skurkovich, S.V., I.E. Volkov, V.M. Delyagin, et al. 2003. First use of anti-interferon (IFN)-\u03b3 in the treatment of type I diabetes in children [Abstract]. Eighth International Workshop on Autoantibodies and Autoimmunity, Berlin."},{"key":"10.1196\/annals.1361.113-BIB33","first-page":"451","article-title":"Successful anti-cytokine therapy using antibodies to IFN-\u03b3, IFN-\u03b1, and TNF-\u03b1 in patients with acute rheumatoid arthritis (RA), psoriatic arthritis (PA) and schizophrenia","volume":"9","author":"Skurkovich","year":"1998","journal-title":"Eur. Cytok. Network"},{"key":"10.1196\/annals.1361.113-BIB34","unstructured":"34Skurkovich, S., N. Korotky, N.M. Sharova & B. Skurkovich. 2004. Successful anticytokine therapy in psoriasis [Abstract]. Ninth International Congress of Dermatology, Beijing."},{"key":"10.1196\/annals.1361.113-BIB35","unstructured":"35Skurkovich, S., N. Korotky, N.M. Sharova & B. Skurkovich. 2004. Successful treatment with anti-IFN-\u03b3 of alopecia areata (AA) [Abstract]. Ninth International Congress of Dermatology, Beijing."},{"key":"10.1196\/annals.1361.113-BIB36","unstructured":"36Skurkovich, S., N. Korotky, N. Sharova & B. Skurkovich. 2002. Anti-interferon-\u03b3 to treat alopecia areata, psoriasis vulgaris, vitiligo, pemphigus vulgaris, and epidermolysis bullosa. In Proceedings of the 5th Asia Pacific Congress of Allergology and Clinical Immunology. Y.-Y. Kim, et al., Eds.: 121-125. Monduzzi Editore. Bologna."},{"key":"10.1196\/annals.1361.113-BIB37","unstructured":"37Skurkovich, S., V.M. Delyagin, A.G. Rumyantsev, et al. 2003. Anti-IFN-\u03b3 in the treatment of rheumatoid arthritis-associated uveitis in children [Abstract]. Eighth International Workshop on Autoantibodies and Autoimmunity, Berlin."},{"key":"10.1196\/annals.1361.113-BIB38","doi-asserted-by":"crossref","unstructured":"38Skurkovich, S., B. Skurkovich, N. Korotky, et al. 2005. Anti-IFN-gamma As a Universal Treatment for Th1 Mediated Skin Diseases [Abstract]. Federation of Clinical Immunology Societies, Boston.","DOI":"10.1586\/1744666X.1.1.11"},{"key":"10.1196\/annals.1361.113-BIB39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000249558","article-title":"T-cell subsets in acne rosacea lesions and the possible role of Demadex folliculorum","volume":"169","author":"Rufli","year":"1984","journal-title":"Dermatologica"},{"key":"10.1196\/annals.1361.113-BIB40","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1128\/IAI.72.7.3706-3715.2004","article-title":"Simultaneous deficiency in CD28 and STAT6 results in chronic ectoparasite-induced inflammatory skin disease","volume":"72","author":"Liu","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1196\/annals.1361.113-BIB41","first-page":"105","article-title":"Immunohistochemical detection of interferon-gamma-producing cells in dermatophytosis","volume":"11","author":"Koga","year":"2001","journal-title":"Eur. J. Dermatol."},{"key":"10.1196\/annals.1361.113-BIB42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-0714.2003.00077.x","article-title":"Th-1 cytokines in oral lichen planus","volume":"32","author":"Khan","year":"2003","journal-title":"J. Oral. Pathol. Med."},{"key":"10.1196\/annals.1361.113-BIB43","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1523-1747.2000.00919.x","article-title":"Skin CD4+ T cells produce interferon-gamma in vitro in response to streptococcal antigens in chronic plaque psoriasis","volume":"114","author":"Brown","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1196\/annals.1361.113-BIB44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.0022-202X.2004.23216.x","article-title":"Serum antibodies against human intracisternal A-type particle (HIAP) endogenous retrovirus in alopecia areata patients: a hallmark of autoimmune disease? J","volume":"123","author":"Placa","year":"2004","journal-title":"Invest. Dermatol."},{"key":"10.1196\/annals.1361.113-BIB45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-0378(01)00117-6","article-title":"Interferon-gamma levels are upregulated by 17-beta-estradiol and diethylstilbestrol","volume":"52","author":"Karpuzoglu-Sahin","year":"2001","journal-title":"J. Reprod. Immunol."},{"key":"10.1196\/annals.1361.113-BIB46","doi-asserted-by":"crossref","unstructured":"46Faergemann, J., J.C. Jones, O. Hettler & Y. Loria. 1996. Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrhoeic dermatitis: new treatment options. Br. J. Dermatol. 134 (Suppl. 46): 12-15 (discussion, 38).","DOI":"10.1111\/j.1365-2133.1996.tb15652.x"},{"key":"10.1196\/annals.1361.113-BIB47","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0090-1229(87)90146-2","article-title":"A unifying model of the immunoregulatory role of the interferon system: can interferon produce disease in humans? Clin","volume":"43","author":"Skurkovich","year":"1987","journal-title":"Immunol. Immunopathol."},{"key":"10.1196\/annals.1361.113-BIB48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/aid.1991.7.545","article-title":"Regulation of tumor necrosis factor receptor expression by acid-labile interferon-alpha from AIDS sera","volume":"7","author":"Lau","year":"1991","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1196\/annals.1361.113-BIB49","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1128\/JVI.76.22.11710-11714.2002","article-title":"Elevated levels of tumor necrosis factor alpha (TNF-alpha) in human immunodeficiency virus type 1-transgenic mice: prevention of death by antibody to TNF-alpha","volume":"76","author":"De","year":"2002","journal-title":"J. Virol."},{"key":"10.1196\/annals.1361.113-BIB50","first-page":"407","article-title":"Infliximab in the treatment of an HIV positive patient with Reiter's syndrome","volume":"30","author":"Gaylis","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1196\/annals.1361.113-BIB51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00002030-200401230-00015","article-title":"A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis","volume":"18","author":"Wallis","year":"2004","journal-title":"AIDS"},{"key":"10.1196\/annals.1361.113-BIB52","first-page":"417","article-title":"Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome","volume":"46","author":"Vadhan-Raj","year":"1986","journal-title":"Cancer Res."},{"key":"10.1196\/annals.1361.113-BIB53","unstructured":"53Bellanti, J.A., S.V. Skurkovich, S.M. Peters & G. Arias. 1987. Treatment of AIDS patients with anti-alpha IFN: an alternative approach. Second Annual Conference on Clinical Immunology of the Clinical Immunology Society, Washington, DC."},{"key":"10.1196\/annals.1361.113-BIB54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0306-9877(94)90031-0","article-title":"A disturbance of interferon synthesis with the hyperproduction of unusual kinds of interferon can trigger autoimmune disease and play a pathogenetic role in AIDS: the removal of these interferons can be therapeutic","volume":"42","author":"Skurkovich","year":"1994","journal-title":"Med. Hypotheses"},{"key":"10.1196\/annals.1361.113-BIB55","first-page":"358","article-title":"Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (the EURIS study)","volume":"20","author":"Gringeri","year":"1999","journal-title":"J. AIDS Hum. Retrovirol."},{"key":"10.1196\/annals.1361.113-BIB56","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/104454902760330147","article-title":"Targeting Tat and IFN (alpha) as a therapeutic AIDS vaccine","volume":"21","author":"Gallo","year":"2002","journal-title":"DNA Cell Biol."},{"key":"10.1196\/annals.1361.113-BIB57","first-page":"292","article-title":"Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the localisata variant of recessive dystrophic epidermolysis bullosa","volume":"59","author":"Gardella","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1196\/annals.1361.113-BIB58","first-page":"846","article-title":"Cytokine-induced cell death in human oligodendroglial cell lines","volume":"76","author":"Buntinx","year":"2004","journal-title":"II: alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha. J. Neurosci. Res."},{"key":"10.1196\/annals.1361.113-BIB59","unstructured":"59Korotky, N.G., N.M. Sharova, B. Skurkovich & S. Skurkovich. 2004. Striking therapeutic effects in a patient with dysplastic epidermolysis bullosa using anti-IFN-\u03b3 (case report). Ninth International Congress of Dermatology, Beijing."},{"key":"10.1196\/annals.1361.113-BIB60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archderm.1992.01680120073006","article-title":"Peripheral blood mononuclear cell subsets in patients with severe inherited forms of epidermolysis bullosa","volume":"128","author":"Chopra","year":"1992","journal-title":"Arch. Dermatol."},{"key":"10.1196\/annals.1361.113-BIB61","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archderm.1989.01670180069008","article-title":"Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa","volume":"125","author":"Tyring","year":"1989","journal-title":"Arch. Dermatol."},{"key":"10.1196\/annals.1361.113-BIB62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916930290005864","article-title":"The role of NK cells in autoimmune disease","volume":"35","author":"Baxter","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1196\/annals.1361.113-BIB63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2249.2003.02183.x","article-title":"Dysregulated expression of IFN-gamma and IL-10 and impaired IFN-gamma-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection","volume":"133","author":"Singh","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1196\/annals.1361.113-BIB64","first-page":"637","article-title":"In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis","volume":"9","author":"Serra","year":"2003","journal-title":"J. Neurovirol."},{"key":"10.1196\/annals.1361.113-BIB65","doi-asserted-by":"crossref","unstructured":"65Moreland, L.W. 2004. Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis. Pharmacoeconomics. 22 (2 Suppl): 39-53.","DOI":"10.2165\/00019053-200422001-00005"},{"key":"10.1196\/annals.1361.113-BIB66","doi-asserted-by":"crossref","unstructured":"66Scott, D.L. 2004. Pursuit of optimal outcomes in rheumatoid arthritis. Pharmacoecomics 22 (2 suppl): 13-26.","DOI":"10.2165\/00019053-200422001-00003"},{"key":"10.1196\/annals.1361.113-BIB67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1568010043343903","article-title":"Targeting tumor necrosis factor-alpha in the therapy of psoriasis","volume":"3","author":"Gisondi","year":"2004","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"10.1196\/annals.1361.113-BIB68","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1517\/14656566.5.7.1497","article-title":"Anti-TNF-alpha therapy in ankylosing spondylitis","volume":"5","author":"Wendling","year":"2004","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1196\/annals.1361.113-BIB69","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/09546630410017275","article-title":"A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab","volume":"15","author":"Scheinfeld","year":"2004","journal-title":"J. Dermatolog. Treat."},{"key":"10.1196\/annals.1361.113-BIB70","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archderm.140.8.1012-a","article-title":"Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles","volume":"140","author":"Etefagh","year":"2004","journal-title":"Arch. Dermatol."},{"key":"10.1196\/annals.1361.113-BIB71","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/art.20303","article-title":"Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial","volume":"50","author":"Nishimoto","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1196\/annals.1361.113-BIB72","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.8100367","article-title":"Induction of type I diabetes by interferon-alpha in transgenic mice","volume":"260","author":"Stewart","year":"1993","journal-title":"Science"},{"key":"10.1196\/annals.1361.113-BIB73","doi-asserted-by":"crossref","unstructured":"73Wauben-Penris, P.J., D.P. Cerneus, W.E. van den Hoven, et al. 1998. Immunomodulatory effects of tretinoin in combination with clindamycin. J. Eur. Acad. Dermatol. Venereol. 11 (Suppl 1): S2-S7.","DOI":"10.1111\/j.1468-3083.1998.tb00900.x"},{"key":"10.1196\/annals.1361.113-BIB74","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.0.CO;2-6","article-title":"Vitamin D3: a transcriptional modulator of the interferon-gamma gene","volume":"28","author":"Cippitelli","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1196\/annals.1361.113-BIB75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0300-483X(02)00257-3","article-title":"Ultraviolet radiation and autoimmune disease: insights from epidemiological research","volume":"181-182","author":"Ponsonby","year":"2002","journal-title":"Toxicology"},{"key":"10.1196\/annals.1361.113-BIB76","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0091-6749(96)80161-8","article-title":"Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study","volume":"97","author":"Thepen","year":"1996","journal-title":"Allergy Clin. Immunol."},{"key":"10.1196\/annals.1361.113-BIB77","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s001250051372","article-title":"Th1-like dominance in high-risk first-degree relatives of type I diabetic patients","volume":"43","author":"Karlsson","year":"2000","journal-title":"Diabetologia"},{"key":"10.1196\/annals.1361.113-BIB78","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1006\/cyto.2000.0786","article-title":"Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes","volume":"12","author":"Vreugdenhil","year":"2000","journal-title":"Cytokine"},{"key":"10.1196\/annals.1361.113-BIB79","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000024271","article-title":"Distinct serum cytokine levels in drug- and measles-induces exanthema","volume":"120","author":"Hari","year":"1999","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1196\/annals.1361.113-BIB80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-5728(91)90106-H","article-title":"Interferon-gamma secretion by in vivo activated cytotoxic T lymphocytes from the blood and cerebrospinal fluid during mumps meningitis","volume":"33","author":"Martin","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1196\/annals.1361.113-BIB81","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF01957751","article-title":"The inflammatory cytokines in measles: correlation between serum interferon-gamma levels and lymphocyte subpopulations","volume":"252","author":"Ohga","year":"1992","journal-title":"Eur. J. Pediatr."},{"key":"10.1196\/annals.1361.113-BIB82","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.170.6.2833","article-title":"IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity","volume":"170","author":"Deng","year":"2003","journal-title":"J. Immunol."},{"key":"10.1196\/annals.1361.113-BIB83","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0306-9877(02)00346-8","article-title":"Anticytokine therapy-new approach to the treatment of autoimmune and cytokine-disturbance diseases","volume":"59","author":"Skurkovich","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1196\/annals.1361.113-BIB84","first-page":"142","article-title":"Are all type I human interferons equivalent? J","volume":"5","author":"Foster","year":"1998","journal-title":"Viral Hepatitis"},{"key":"10.1196\/annals.1361.113-BIB85","unstructured":"85Hayden, D. 2003. Pox: Genius, Madness, and the Mysteries of Syphilis. Basic Books. New York."},{"key":"10.1196\/annals.1361.113-BIB86","first-page":"4757","article-title":"T-cell responses to Treponema pallidum subsp","volume":"67","author":"Arroll","year":"1999","journal-title":"pallidum antigens during the course of experimental syphilis infection. Infect. Immun."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1196%2Fannals.1361.113","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1196\/annals.1361.113\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T08:45:52Z","timestamp":1706517952000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1196\/annals.1361.113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,6]]}},"URL":"https:\/\/doi.org\/10.1196\/annals.1361.113","relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}